Case Study: CRL Optimizes Workflow Efficiency and Data Quality in its in vitro ADME lab

Read Now

It's time to re-imagine the Carcinogenicity Assessment!

Our "Future Proofing Drug Safety: Target Carcinogenicity Risk Assessment Meets ICH S1B(R1) Standards" webcast is now available for you to access anytime, and anywhere.

Watch Now

Case Study: Dermavant Centralizes and Transforms its SCE Overnight with No Delay to its Drug Development Program

Read Now

Advance™ Weight of Evidence Assessments enables R&D organizations to cut study timelines, deliver cost savings and reduce animal experimentation

Learn More

Industry Insights

Join the journey with us by visiting
one of our bi-weekly industry Blogs

Learn More

The future transformed for the benefit of everyone.

Intelligent solutions empowering collaboration and life-enhancing science.


Latest News

Instem to Showcase Enhanced Provantis Pathology Solution at Upcoming STP Symposium

Powerful study management updates provide cutting-edge digital pathology capabilities.

Read More

Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline

Advance™ technology-enabled solution enables R&D organizations to cut study timelines, deliver cost savings and reduce animal experimentation.

Read More

Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact

Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.

Read More

Contact Us

Contact Us

Get in touch and let us know how we can help.